Advertisement
UK markets close in 7 hours 59 minutes
  • FTSE 100

    7,951.54
    +19.56 (+0.25%)
     
  • FTSE 250

    19,758.39
    -52.27 (-0.26%)
     
  • AIM

    741.51
    -0.60 (-0.08%)
     
  • GBP/EUR

    1.1681
    +0.0012 (+0.10%)
     
  • GBP/USD

    1.2608
    -0.0030 (-0.24%)
     
  • Bitcoin GBP

    55,907.86
    +497.40 (+0.90%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • DOW

    39,760.08
    +477.75 (+1.22%)
     
  • CRUDE OIL

    81.77
    +0.42 (+0.52%)
     
  • GOLD FUTURES

    2,213.50
    +0.80 (+0.04%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,477.54
    +0.45 (+0.00%)
     
  • CAC 40

    8,220.49
    +15.68 (+0.19%)
     

GlaxoSmithKline’s Pharmaceuticals Segment in 2Q17

GlaxoSmithKline’s (GSK) Pharmaceuticals segment reported a 3.0% rise in revenues at constant exchange rates and a 9.0% positive impact of foreign exchange in 2Q17.